MYHIXEL
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
MYHIXEL - overview
Established
2017
Location
Sevilla, -, Spain
Primary Industry
Medical Devices & Equipment
About
MYHIXEL, based in Sevilla, Spain, is dedicated to enhancing male intimate health by providing innovative solutions for issues like premature ejaculation and erectile dysfunction through unique devices and programs. Founded in 2017 by Amparo Torres, Andrés Del Toro, and Patricia Trabajo, MYHIXEL specializes in male intimate health solutions. The company has operated with a steady focus on its core offerings and has not undergone significant changes in business strategy. Their headquarters is located in Sevilla, Spain.
As of January 2024, MYHIXEL raised EUR 1. 4 million in funding led by Sego Ventures, supported by Impact Investors and Zubi Capital, bringing the total amount raised to EUR 1. 4 million. MYHIXEL specializes in innovative solutions for male intimate health, focusing on issues such as premature ejaculation and erectile dysfunction.
Their core products include MYHIXEL CONTROL, a program and device to help users manage climax timing, and MYHIXEL RING, an ergonomic device that enhances erection quality and duration. Developed by experts and backed by clinical trials, these products cater to men seeking non-pharmacological treatments for sexual health concerns. In the year 2023, MYHIXEL generated revenue of EUR 1,449,377. 50.
The company operates a direct-to-consumer sales model, allowing customers to purchase MYHIXEL CONTROL and MYHIXEL RING directly from their website, ensuring privacy with discreet packaging. Their sales strategy includes promotional discounts, such as a 5% incentive for newsletter subscribers. In January 2024, MYHIXEL secured EUR 1. 4 million in venture funding to support its growth initiatives.
The company plans to expand its operations, explore new sales avenues, and invest in research for male sexual health. Specific future products are being designed, and plans are in place to enter new geographic markets to broaden its consumer base.
Current Investors
Zubi Capital, Impact Investors, Sego Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Therapeutic Devices
Website
www.myhixel.com/
Verticals
Artificial Intelligence
Company Stage
Early Stage
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.